
How to Apply for the RDI Fund: Eligibility, Documents and the Application Process
Most of the work in an RDIF application happens before you submit anything, so start with the seven tests.
Summary
- A company controlled by resident Indian citizens and headquartered in India, with a lab-validated technology (TRL 4 or above) in a priority sector, can apply.
- As of October 2026 there are 21 approved fund managers, and the application goes to one of them, never to RDIF directly.
- RDIF gives no grants and covers at most half the project, and the other half must come from non-government sources.
This guide is the operating manual for an RDI Fund application. It covers who qualifies and who does not, which manager to approach, the steps in order, the documents and why applications fail.
It is written for founders and CFOs of deep-tech startups, SMEs and larger companies preparing for an RDIF raise in the next 6 to 12 months. For what the ₹1 lakh crore fund is and how its money flows, read our companion piece, RDIF funding: a founder's guide.
Three facts shape everything below.
- RDIF gives no grants. It funds through long-term loans, convertible debt or , and it makes no short-term loans.
- RDIF covers at most 50%. That is 50% of the assessed project cost for debt, or of each round's value for equity.
- The manager decides. Each fund manager's own investment committee chooses, on its own timeline. RDIF does not evaluate individual investment decisions.
Who is eligible: the seven tests
We group the rules into seven tests. Fail any one and no manager can fund you, however good the technology. Most come from the revised RDIF Implementation Guidelines of 7 January 2026, in force as of October 2026. The non-government match comes from RDIF's later clarification.
1. You are an Indian legal entity
Any legal entity registered in India qualifies. That covers a company under the Companies Act 2013, a partnership under the Indian Partnership Act 1932 and an LLP under the LLP Act 2008. DPIIT-recognised startups are included.
BIRAC, the Biotechnology Industry Research Assistance Council, has opened its call to startups, SMEs and large industries. If you want equity from an RDIF-backed (AIF), in our view you need a company, not an LLP or partnership. In our experience, VCs rarely take equity in LLPs or partnerships.
2. Control and global headquarters stay in India
The company must be controlled by resident Indian citizens, as "control" is defined in DPIIT's Consolidated FDI Policy (2020). Its registered global headquarters must be in India, so that global revenue and profit consolidate in the Indian entity.
Foreign investors on the are fine as long as control stays with resident Indians. Watch board-appointment rights and affirmative-vote clauses in your shareholder agreement. The FDI Policy counts the right to appoint a majority of directors, or to control management or policy decisions, as control, even without majority shareholding.
A flipped structure fails. A Delaware or Singapore parent with an Indian operating subsidiary does not qualify, and an Indian subsidiary of a foreign company fails for the same reason. The guidelines never say "flipped", but the headquarters test rules it out.
3. Your technology is at TRL 4 or above
Technology readiness level (TRL) is a nine-step scale that runs from basic research to a proven product. Under the national framework, TRL 4 is component or system validation in a laboratory. RDIF reads it as having at least a laboratory-level prototype. We would add repeatable test data, because a technical reviewer will want to see it.
RDIF does not demand a TRL certificate. Managers can refer to NTRAF, the National Technology Readiness Assessment Framework from the Office of the Principal Scientific Adviser. Our guide to technology readiness levels walks through it level by level.
The Technology Development Board (TDB), a statutory body under the Department of Science and Technology, is one of the two government managers. Its first 22 approved projects started anywhere from TRL 4 to TRL 8, with targets of TRL 6 to 9. Higher readiness is not a disadvantage.
4. The technology is R&D-intensive
RDIF funds technologies with real uncertainty in functionality, adoption, production or standards. Low-end technology projects and routine R&D are excluded. A product upgrade, a new feature on proven technology or a localisation of a mature product will struggle to qualify.
5. You are in a priority sector
The guidelines name energy security and climate action; deep tech, such as quantum, robotics, space and semiconductors; and AI applied to agriculture, health and education. They also name biotech, biomanufacturing, synthetic biology, pharma and medical devices; the digital economy; and technologies vital for strategic or economic security.
The Empowered Group of Secretaries (EGoS), chaired by the Cabinet Secretary, can add sectors. At its meeting on 8 October 2026 it approved five more technologies, which had not been named publicly as of 15 October 2026.
6. You have a defined project
Debt funding is sized against a project proposal with clearly defined deliverables and outcomes. Equity is sized against a funding round that covers the full cost of the objectives you state. Technology acquisition can be financed, but only within a wider project that leads to a product.
7. You can fund the other half
RDIF money cannot exceed 50% of the assessed project cost or round. The balance must come from the company itself or from non-governmental commercial sources, such as private investors, strategic partners or commercial loans. Government grants do not count toward it. Ask the manager before counting a loan from a public-sector bank.
The EGoS can relax the cap "in exceptional types of projects/sectors". Do not plan on it.
Edge cases at a glance
Common situations tested against the seven rules, as of October 2026. The DPIIT, LLP, foreign-VC and university rows apply the rules as we read them.
| Situation | Eligible? | Why |
|---|---|---|
| DPIIT-recognised private limited startup, Indian founders | Yes | If tests 2 to 7 are met |
| LLP or partnership firm | Yes, best suited to loans | Eligible in law; in our view, equity from AIFs is impractical |
| Foreign VC holds 40%, Indian founders control the board | Usually yes | Control, not shareholding, decides; check the rights in the shareholder agreement |
| US parent company with an Indian subsidiary | No | The global headquarters must be in India |
| Growth-stage company with revenue | Yes | No norms on revenue, stage or size, if the project is R&D-intensive |
| Large listed company | Yes | TDB and BIRAC fund corporates; Tejas Networks and Ather Energy were in TDB's first round |
| Government entity or CPSE | No | Only on a strategic project in partnership with the private sector |
| University lab, no company yet | No | Incorporate first; in our view, TRL 1 to 3 research belongs with ANRF grants |
| No tie-up with an academic institution | Yes | Not required |
Self-check: do you qualify?
Work down the seven rules in order. Any "no" means fix that gap before you approach a manager, and the order also reflects which fixes take longest.
- You are a legal entity registered in India. If not, incorporate in India first.
- Resident Indians control the company, and its global headquarters is in India. If not, reverse the flip or restructure control.
- A lab-validated prototype puts you at TRL 4 or above. If not, use grants to reach TRL 4 first.
- The work carries real R&D uncertainty. Routine development does not count, and a project that is only that is not an RDIF project.
- You are in an RDIF priority sector. If you sit at its edge, make your strategic relevance explicit.
- You have a defined project with milestones. If not, scope the project and its budget first.
- The matching 50% is identified from non-government sources. If not, line up the private half first.
Seven yeses mean you are ready to approach a manager. Then pick your route: TDB, BIRAC or one of the 19 cohort managers.
Which route fits your company?
Pick the route by the instrument you want and your stage. TDB suits debt-heavy scale-up projects in any priority sector, and BIRAC suits biotech. The 19 cohort managers, 14 AIFs and 5 Focused Research Organisations (FROs), suit companies that also want equity and an active investor.
The four routes to RDIF money, as of 15 October 2026. The AIF instrument mix and the best-for row are our view.
| TDB | BIRAC | RDIF-backed AIFs (14) | RDIF-backed FROs (5) | |
|---|---|---|---|---|
| Sectors | All priority sectors | Biotechnology and allied areas | Each fund's own thesis | Each FRO's focus |
| Instruments | Collateral-free long-term loans; optionally convertible debt, sold as a soft loan with deferred equity; upfront equity support | Co-investment of ₹5 to 200 crore per company | Mostly equity, some venture debt | Loans, equity or a mix |
| How you apply | Open calls (first call opened 4 Feb 2026) | Online application at biracrdif.org | Pitch like any investor | Approach the FRO |
| Decided by | TDB Investment Committee | BIRAC evaluation | The fund's investment committee | The FRO's investment committee |
| Status (October 2026) | Intake paused after 30 Sep 2026; 35 companies selected over two rounds; no new call announced | Phase 1 closed 31 Mar 2026; evaluation in progress; no new call announced | Approved Oct 2026; deploy once RDIF agreements are signed | Approved Oct 2026; deploy once RDIF agreements are signed |
| Best for | Larger scale-up projects; companies that prefer debt to dilution | Biotech platforms and indigenous biomanufacturing | Startups raising a priced round | Campus-linked and lab-spun companies |
The EGoS approved the first cohort on 8 October 2026, and RDIF announced it on 12 October with an aggregate approved commitment of ₹7,131 crore. RDIF has not published each manager's share.
The 14 AIFs are Speciale Invest, YourNest, Sixth Sense Ventures, Chiratae, Kalaari, Celesta, AdvantEdge, IvyCap, Ideaspring, Blume, TVS Capital, AMA Capital, Translation Endeavors and Campus. The five FROs are ARTPARK (IISc), CCAMP, IIT Madras Research Park, PIEDS (BITS Pilani) and SINE (IIT Bombay).
You can run routes in parallel. A company can pitch an RDIF-backed AIF for equity while applying to TDB for project debt when it next opens a call. Total RDIF money must stay within 50% of each project or round. Disclose every application to each manager.
The application, step by step
Most of the work happens before you submit anything. This is the sequence we follow with clients, and steps 1 to 5 decide whether steps 6 to 10 go smoothly.
Most of the work happens before you submit anything.
- Confirm eligibility. Run the seven tests above. Fix ownership or domicile issues first, because they take the longest.
- Assess your TRL honestly. Self-assess each critical subsystem against NTRAF, which rates each critical technology element separately. Investors will read your overall TRL as that of your weakest critical component. Assemble the test data that proves it.
- Define the project. Set a start TRL and a target TRL, three to six milestones with measurable deliverables, a timeline and a costed budget. TDB's approved projects state both, with starting TRLs from 4 to 8 and targets from 6 to 9.
- Build the capital stack. Decide the mix of debt, convertible debt and equity. Size RDIF at no more than 50%, and line up the matching half from non-government sources: a , a board resolution committing internal funds, or a sanctioned loan.
- Build the financial model. Show the project's cash needs by milestone, the revenue path after it, and how concessional debt is serviced after the moratorium or converts.
- Choose the manager. Match sector, instrument and against the route table, since each manager sets its own ticket size. For AIFs, check the fund's thesis and recent investments.
- Submit. For TDB, apply during an open call. For BIRAC, apply online at biracrdif.org during an open call. For AIFs and FROs, send a deck and project summary, then share the data room under NDA.
- Go through evaluation and diligence. Expect technical review by domain experts, financial and legal diligence, site visits and an investment committee presentation. Background checks on founders and promoters are standard.
- Negotiate and sign. A sanction letter or term sheet leads to a loan, optionally convertible debt (OCD) or shareholder agreement. It sets the interest, moratorium, conversion terms, milestones, covenants and reporting obligations.
- Draw down and report. In our experience, money is released against milestones. You report progress to the manager, which reports to RDIF every half-year and every year.
Which documents should you have ready?
Each manager has its own templates. In our experience, though, every investment committee asks for the evidence below. Have it ready before you approach anyone, because assembling it under diligence pressure is where weeks are lost.
- Corporate and eligibility. Certificate of incorporation and MoA/AoA, or the LLP or partnership deed. DPIIT startup recognition, if you have it. The fully diluted cap table and shareholder agreements, showing resident-Indian control. Board composition and any investor rights over appointments or reserved matters. Proof that the Indian entity is the global headquarters.
- Technology. A technical note on the problem, the technology and why it is R&D-intensive. A TRL self-assessment against NTRAF, subsystem by subsystem. Test reports and raw data behind the claimed TRL, with third-party validation where possible. An IP schedule covering patents filed or granted, ownership, assignment from founders or universities, and a freedom-to-operate view.
- Team. CVs for the technical leads.
- Project. The project proposal, with start and target TRL, milestones, deliverables and timeline. A budget costed by milestone and by category: capex, people, materials, testing and certification. The manufacturing or scale-up plan and main suppliers. Market evidence such as pilots, letters of intent, purchase orders and procurement interest.
- Financial. Audited financials for the last three years, or since incorporation. Current management accounts and cash position. A financial model with project cash flows, the revenue plan and the debt-service or conversion schedule. Evidence of the matching 50%: a term sheet, board resolution or loan sanction. The existing debt schedule and charges.
- Compliance. Statutory filings up to date for ROC, GST, income tax, TDS and PF/ESI. filings for any foreign investment. A statement of litigation and contingent liabilities. KYC and background details of promoters and directors.
How proposals are judged, and why they fail
The first round was selective. TDB received 124 applications, evaluated 51 in depth and selected 22, roughly one in six. Knowing what the evaluators weigh is a large part of landing among the 22.
What do evaluators weigh?
Parliament was told in July 2026 that selection looks at innovation, TRL, commercialisation potential, market, team, implementation plan and strategic impact. The fuller list we work from has seven questions.
- Technical merit and readiness. Is the TRL claim real, and is the target TRL achievable with this budget?
- R&D intensity and national relevance. Does it build Indian IP in a strategic or sunrise area, or substitute critical imports?
- Defensible IP. Can the intellectual property be protected, and does the company own it?
- Manufacturability. Can it be produced at a cost the market will bear?
- Market. Is there a real buyer, shown by named customers, pilots or procurement interest?
- Capital mobilised. How firm is the matching private money?
- Team. Does the team have the technical depth and execution record for the milestones?
What TDB's first round tells you
TDB's first RDI round, approved by 30 April 2026
| Signal | First-round data |
|---|---|
| Companies selected | 22, across 5 states |
| Total approved project cost | ₹4,744 crore |
| Total TDB (RDIF) assistance | ₹2,192 crore, about 46% of project cost |
| Assistance per company | ₹3 crore to ₹285 crore; about ₹100 crore on average |
| Instrument mix | 17 optionally convertible debt, 5 straight debt |
| Sector mix | 13 deep tech, 4 biotech, pharma or medtech, 3 energy, 1 digital economy, 1 AI |
| Starting TRL | Mostly 4 to 6; one at 7 and one at 8 |
| Target TRL | 6 to 9 |
Two lessons follow. Optionally convertible debt was the most common instrument, used in 17 of 22 projects, so model what conversion does to your cap table. Deep tech dominated, with a tilt to space, quantum and robotics, so companies outside those areas should make their strategic relevance explicit.
Gaps that sink applications
In our experience, these are the gaps most likely to stop an application.
- An inflated TRL that collapses under technical review.
- Routine R&D presented as breakthrough work.
- No firm matching capital, only "in discussions".
- Control or domicile problems found in the cap table or shareholder agreement.
- IP owned by founders or a university, not by the company.
- Vague milestones that cannot be measured or tied to disbursement.
- A repayment plan built on optimistic revenue, with no downside case.
- Compliance gaps that stall diligence, such as overdue filings, FEMA lapses or unreconciled books.
Timelines, costs and what you owe after funding
How long does it take?
RDIF sets no deadline for a manager's decision, and each manager follows its own process. TDB's first call opened on 4 February 2026, and its first round was approved by 30 April 2026, about three months later.
Disbursement can lag selection. Outlook Business reported on 1 October 2026 that TDB's 13 second-round companies were still waiting on letters of intent and fresh funding. TDB says there is no shortage of funds. It stopped accepting applications after 30 September 2026, citing administrative reasons.
Our working assumption is 4 to 9 months from first approach to first money. Do not let your depend on a fixed date.
What does the money cost?
- Interest has no published scheme rate. RDIF sets the rate it charges each manager case by case, and TDB describes a "nominal interest rate". At the launch of TDB's first call, the Minister of State for Science and Technology put the fund's financing at around 2-4% (PIB, 4 February 2026).
- The manager's margin is capped. A manager lending RDIF money may keep a net interest margin of at most 3%, a cap ANRF's Executive Council can change.
- Tenure is long, and the moratorium must be passed on. TDB's loan tenure runs up to 15 years, moratorium included. The guidelines require an adequate moratorium on principal and interest, which may run at least until commercialisation starts. Managers must pass on at least 75% of the tenor they get from RDIF, with no prepayment penalty.
- Loans are expected to be unsecured. TDB describes its loans as collateral-free.
- Conversion depends on the product. TDB's optionally convertible debt is a soft loan with deferred equity. Up to 20% of the sanctioned debt can convert into equity at a pre-agreed discount. Its separate upfront equity support puts up to 25% of TDB's assistance in as equity, with the rest as loan. TDB's stake is capped at 25% of total shareholding. Elsewhere, the manager and the company negotiate conversion terms.
- Equity is priced by the manager. The manager's investment committee sets the price, and RDIF does not evaluate individual investment decisions.
What do you owe after funding?
- Reporting runs through the manager. You report milestones to the manager, which reports to RDIF within 60 days of each half-year and 90 days of each financial year end.
- RDIF can look in. It can visit funded companies, and it can managers through a professional agency.
- Use of funds is fixed. In our experience, the money is tied to the approved project, and diversion is treated as a default.
- Covenants follow the instrument. In our experience, typical ones are information rights, board or observer seats for equity and , and limits on further debt or change of control.
Treat reporting as an asset. A clean milestone record is what releases the next tranche, and it anchors your next round's valuation.
A clean milestone record is what releases the next tranche, and it anchors your next round's valuation.
Frequently asked questions
How do you apply for the RDI Fund?
Through one of its 21 approved fund managers, never to RDIF directly. TDB and BIRAC take applications during open calls. The 14 AIFs and 5 FROs take a pitch like any investor, and deploy RDIF money once their agreements with RDIF are signed.
What are the RDI Fund eligibility criteria?
We group them into seven tests, and you need all of them. You must be an Indian legal entity, controlled by resident Indian citizens, with your global headquarters in India. Your technology must be R&D-intensive, at TRL 4 or above, in a priority sector. You need a defined project and a non-government match for at least half its cost. Government entities and CPSEs are excluded unless they partner the private sector on a strategic project.
Is there an RDI Fund application form or portal?
There is no single RDIF form for companies. TDB took applications through its open call, and BIRAC uses its own portal, biracrdif.org. The AIFs and FROs have no RDIF form, so you approach them as you would any investor.
When is the next tdb rdi call?
None had been announced as of 15 October 2026. TDB stopped accepting applications after 30 September 2026, citing administrative reasons. The press linked the pause to a funding gap, and TDB says there is no shortage. Watch tdb.gov.in and the RDIF portal.
Can biotech startups apply through the birac rdi fund?
Yes. BIRAC's call is open to startups, SMEs and large industries in biotechnology and allied areas, with co-investment of ₹5 to 200 crore per company. Phase 1 of its first national call closed on 31 March 2026.
As of July 2026, BIRAC had shortlisted 8 projects involving ₹390.35 crore, and its portal says evaluation is still in progress. No second call had been announced as of October 2026.
Can government grants count toward the matching 50%?
No. The match must come from the company itself or from non-governmental commercial sources. It can include the manager's own money, if that money comes from the manager's non-government investors.
Does my startup need DPIIT recognition?
No. Any legal entity registered in India can qualify, recognised or not.
We have no revenue yet. Can we still apply?
Yes. RDIF sets no norms on revenue, stage or workforce size, and it funds from TRL 4, well before revenue. You still need a credible market and the matching 50%.
What if we are at TRL 3?
You are not eligible yet. Use research grants from ANRF, DST or DBT to reach a lab-validated prototype, then apply. Our grants and schemes guide covers the options, including the NIDHI-PRAYAS prototype grant.
Can RDIF fund buying a technology from abroad?
Only as part of a wider project to develop a product. Technology acquisition on its own does not qualify.
Will RDIF take a board seat?
RDIF invests only through managers, so it never holds a direct stake in your company. The manager that invests may take board or observer rights, as in any investment.
How SRF helps on an RDIF raise
We run the finance side of RDIF applications for deep-tech founders. That means the eligibility and structure review, the project budget and model, the matching round, a diligence-ready data room and the pitch to the right manager. SRF is an independent advisory firm, not an RDIF fund manager.
General guidance, as of October 2026. Calls, caps and terms change, and the manager's sanction letter or term sheet beats anything written here. If you want a readiness review before you approach a manager, our capital-raising practice starts there.
Sources
- RDIF Implementation Guidelines (revised 7 January 2026) and RDIF's modification and clarification of them, rdifund.anrf.gov.in
- RDIF Frequently Asked Questions, rdifund.anrf.gov.in, 2026
- Pib: rdi funding to start by end of month, TDB and BIRAC approved, 19 January 2026
- PIB: RDIF announces first cohort of 19 second-level fund managers, 12 October 2026; RDIF cohort notice, October 2026
- PIB: Rajya Sabha reply of 23 July 2026 and Lok Sabha reply of 29 July 2026 on the RDI Fund
- Tdb: rdi presentation with terms and the 22 approved projects, 2 June 2026
- Birac-rdi Fund portal, biracrdif.org, accessed 15 October 2026; BioSpectrum on BIRAC's first national call, 14 February 2026
- PIB on the launch of TDB's first call, 4 February 2026; ANI on TDB's 124 proposals, 13 May 2026
- Indian Express investigation, summarised by Vision IAS, 7 August 2026
- PTI via ThePrint, 30 September 2026; Outlook Business, 1 October 2026
- Office of the Principal Scientific Adviser: National Technology Readiness Assessment Framework
How useful was this article?
One tap. It tells us what to write more of.
The next one
Get what we publish next, by email.
Working notes on raising, borrowing, protecting, growing and structuring capital in India. One email a week at most, and you can leave any time.
We use your address only to send this. See our privacy policy.
We store your address to send you these emails and nothing else. See our privacy policy.
The services behind this article
What we do about it, for founders and finance teams. Each has its own page.

RDI Fund Capital Raise
Advisory on the RDI Fund for startups at TRL 4+: readiness diagnostic, the matching 50%, project model, data room and fund manager mapping.

Venture Capital & Private Equity
Investment readiness, fundraising strategy, diligence preparation and transaction support for founders raising institutional equity.

Government Grants & Schemes
Identifying, applying for and staying compliant with the non-dilutive government funding a business already qualifies for.

Debt & Blended Finance
Working capital, venture debt and blended structures for businesses that should not be raising equity.








